Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk.
about
Paraoxonase 1 gene polymorphism does not affect clopidogrel response variability but is associated with clinical outcome after PCILDL particle size: an important drug target?Lipid composition influences the shape of human low density lipoprotein in vitreous iceA common genetic mechanism determines plasma apolipoprotein B levels and dense LDL subfraction distribution in familial combined hyperlipidemia.Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapyLow density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugsThe association between the apolipoprotein A1/ high density lipoprotein -cholesterol and diabetes in Taiwan - a cross-sectional studyPatient considerations and clinical impact of cholesteryl ester transfer protein inhibitors in the management of dyslipidemia: focus on anacetrapib.Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering Agents.Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy.Relationship between Aortic Intima-media Thickening, Serum IGF-I and Low-density Lipoprotein Particle Diameter in Newborns with Intrauterine Growth Restriction.High density lipoprotein particle size in children: relation to atherogenic dyslipidemia.Low carbohydrate diets improve atherogenic dyslipidemia even in the absence of weight loss.Purification and Characterization of a Lovastatin Esterase from Clonostachys compactiuscula.The Association Between Small Dense Low Density Lipoprotein and Coronary Artery Disease in North Indian Patients.
P2860
Q28486151-72AB94C0-FCEC-47C3-BA4B-26D6D58C6428Q33693960-C77E2C5E-A287-495B-8FF4-793A5C18917CQ34074785-65A36C91-2D12-456F-B325-6E6DC0816AC7Q34386536-043EE61E-75D8-42B5-A5FD-418204DD5D32Q34417470-96DE1DA8-CD93-4282-9CAC-F83FFC4482B5Q34800220-39DD728D-1A76-4A73-88F0-9E1B64C23A5BQ35008066-D69C2FA2-A325-48EF-830E-6837D9050D86Q36197709-E7E67B90-52D2-4381-896D-2F3C9F8509ACQ37074239-33E90B78-1450-4409-B262-D991EB2780A5Q37086312-8C7365F8-34A8-412E-B636-816BA1758F5CQ37732830-C8056A85-7AAF-4C1E-9AF6-042196AB5D93Q37732834-14656178-F88D-48A1-A5DB-F72C6AE28609Q41500821-8C39DA70-EFAB-4D7E-BBA2-A3DDC19D54E0Q43232124-7D0D52CC-E2C2-4983-A892-FCB72CB21143Q51268637-BADEB6CF-F813-43FA-90EE-2D536DE434F6
P2860
Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk.
@en
type
label
Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk.
@en
prefLabel
Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk.
@en
P1476
Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk.
@en
P2093
P304
P577
1994-10-01T00:00:00Z